AB Science
Pre-Approval PRO BETAPipeline by Phase
Therapeutic Focus
Clinical Trials (24)
Efficacy and Safety of Masitinib Versus Placebo in the Treatment of ALS Patients
Started: 2/2/2021
Masitinib in Patients With Mild Alzheimer's Disease
Started: 6/1/2026
Efficacy and Safety of Masitinib in Combination With SoC Versus Placebo in the Treatment of ALS Patients
Started: 1/1/2026
Masitinib in the Treatment of Patients With Primary Progressive or Non-active Secondary Progressive Multiple Sclerosis
Started: 6/28/2022
Masitinib in Patients With Mild to Moderate Alzheimer's Disease
Started: 1/1/2012
Masitinib Plus Docetaxel in Metastatic Castration-resistant Prostate Cancer
Started: 9/1/2014
Masitinib in First Line Treatment of Gastro-Intestinal Stromal Tumor (GIST)
Started: 1/1/2009
Masitinib in Treatment of Patients With Severe Persistent Asthma Treated With Oral Corticosteroids
Started: 1/1/2011
Masitinib in the Treatment of Patients With Severe Uncontrolled Asthma and Elevated Eosinophil Levels
Started: 12/1/2016
Masitinib in Patients With Gastrointestinal Stromal Tumour After Progression With Imatinib
Started: 4/1/2012
Masitinib in Non-Resectable or Metastatic Stage 3/4 Melanoma Carrying a Mutation in the Juxta Membrane Domain of c-Kit
Started: 1/1/2011
Efficacy and Safety of Masitinib in the Treatment of Progressive Multiple Sclerosis
Started: 8/1/2011
Masitinib in Severe Indolent or Smoldering Systemic Mastocytosis
Started: 12/1/2008
Masitinib in Combination With FOLFIRI for Second-line Treatment of Patients With Metastatic Colorectal Cancer
Started: 1/1/2014
A Phase 3 Study to Evaluate Efficacy and Safety of Masitinib in Patients With Relapse or Refractory Multiple Myeloma
Started: 5/1/2011
Masitinib in Combination With Gemcitabine for Treatment of Patients With Advanced/Metastatic Pancreatic Cancer
Started: 11/25/2008
Masitinib in Patients With Localized, Primary GIST After Complete Surgery and With High Risk of Recurrence
Started: 7/1/2015
Masitinib in Combination With Riluzole for the Treatment of Patients Suffering From Amyotrophic Lateral Sclerosis (ALS)
Started: 4/1/2013
Masitinib in Combination With FOLFIRI in Third or Fourth Line of Treatment of Patients With Metastatic Colorectal Cancer
Started: 7/1/2015
Masitinib in Combination With Gemcitabine in Advanced/Metastatic Epithelial Ovarian Cancer Patients
Started: 4/1/2014
Masitinib in Refractory Active Rheumatoid Arthritis
Started: 7/1/2011
Masitinib in Patients With Gastro-Intestinal Stromal Tumour Resistant to Imatinib
Started: 10/1/2008
AB8939 in Patients With Relapsed/Refractory Acute Myeloid Leukemia
Started: 6/1/2022